Zonagen Reports Fourth Quarter And Year End 2005 Financial Results

THE WOODLANDS, Texas--(BUSINESS WIRE)--March 13, 2006--Zonagen, Inc. (Nasdaq:ZONA)(PCX:ZONA) today announced financial results for the year and fourth quarter ended December 31, 2005 and provided an update on the Proellex(TM) clinical program.